The BRAIN Initiative® Cell Atlas Network (BICAN) has launched its first major data release, marking a significant milestone in the ambitious effort to map the whole human brain.
CureVac Advances Seasonal Flu Study to Phase 2 in Collaboration with GSK Following Selection of Promising mRNA Vaccine Candidate with Broad Coverage – Biotech Investments
Issuer: CureVac / Key word(s): Study/Study results 12.09.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Advances Seasonal